Canadian Products

We offer a wide range of plasma-derived and recombinant therapeutic products including a variety of products used in the hospital setting for critical care, for primary immunological disorders, and as thrombolytic agents.

The information provided herein is solely for use by physicians and healthcare professionals in Canada. The products listed may not have been approved in other countries and may not be available everywhere.

Transplant Medicine

Cytogam® Cytomegalovirus Immune Globulin Intravenous (HUMAN) (CMV-IGIV) Indicated for attenuation of primary (1°) Cytomegalovirus disease associated with kidney transplantation Product Monograph

Coagulation

	Helixate® FS Antihemophilic Factor (Recombinant)  Indicated for treatment of classical hemophilia (hemophilia A) Product Monograph
	Humate-P® Antihemophilic Factor/von Willebrand Factor Complex (Human) Indicated for treatment of classical hemophilia (hemophilia A) and von Willebrand Disease (vWD) Product Monograph
	Mononine® Coagulation Factor IX (Human) Monoclonal Antibody Indicated for the prevention and control of bleeding Factor IX deficiency, also known as hemophilia B or Christmas disease Product Monograph

Critical Care & Immunology

Critical Care

	Alburex® 5, Alburex® 25 Albumin (Human) 5% Solution, 25% solution Indicated for restoring and maintaining circulating blood volume, in Shock, Burns, Hypoproteinemia with or without edema Product Monograph
	Streptase® Fibrinolytic agent Indicated for the treatment of acute myocardial infarction, pulmonary embolism, deep vein thrombosis, arterial thrombosis and embolism and arteriovenous cannula occlusion Product Monograph

Immunology

	Privigen® Immune Globulin Intravenous (Human) 10% solution  Indicated for the treatment of patients with primary immune deficiency (PID), secondary immune deficiency (SID) and immune thrombocytopenic purpura (ITP) Product Monograph
	Sandoglobulin® NF Liquid Immune Globulin Intravenous (Human), 12% solution  Indicated for treatment of adult and pediatric patients with primary immune deficiency (PID) or secondary immunedefiency (SID) who require immunoglobulin replacement therapy Product Monograph
	Vivaglobin® Immune Globulin Subcutaneous (Human), 16% solution Indicated for treatment of adult and pediatric patients with primary immune deficiency (PID) or secondary immunodeficiency (SID) who require immunoglobulin replacement therapy  Product Monograph